Error | ValueSet.version | Values for version differ: '2.0.0' vs '3.0.0-ballot' |
Information | ValueSet.date | Values for date differ: '2022-05-09T16:53:07+00:00' vs '2023-12-18T22:45:59+00:00' |
Information | ValueSet.publisher | Values for publisher differ: 'HL7 Clinical Genomics Working Group' vs 'HL7 International / Clinical Genomics' |
Name | Value | Comments | |
---|---|---|---|
compose.inactive | |||
compose.lockedDate | |||
copyright | This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc. This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement. | ||
date | 2022-05-09T16:53:07+00:00 | 2023-12-18T22:45:59+00:00 |
|
description | Value Set for terms that describe a predicted ramification based on the presence of associated molecular finding(s). | ||
experimental | false |
| |
immutable | |||
jurisdiction | |||
jurisdiction[0] | http://unstats.un.org/unsd/methods/m49/m49.htm#001 | ||
name | GeneticTherapeuticImplicationsVS | ||
publisher | HL7 Clinical Genomics Working Group | HL7 International / Clinical Genomics |
|
purpose | |||
status | active | ||
title | Genetic Therapeutic Implications | ||
url | http://hl7.org/fhir/uv/genomics-reporting/ValueSet/genetic-therapeutic-implications-vs | ||
version | 2.0.0 | 3.0.0-ballot |
|
Item | Property | Value | Comments | ||
---|---|---|---|---|---|
include | http://loinc.org | ||||
Concept | LA10315-2 | Ultrarapid metabolizer | |||
Concept | LA25391-6 | Normal metabolizer | |||
Concept | LA25390-8 | Rapid metabolizer | |||
Concept | LA10317-8 | Intermediate metabolizer | |||
Concept | LA9657-3 | Poor metabolizer | |||
Concept | LA19542-2 | Low Risk | |||
Concept | LA19541-4 | High Risk | |||
Concept | LA6676-6 | Resistant | |||
Concept | LA6677-4 | Responsive | |||
Concept | LA9660-7 | Presumed resistant | |||
Concept | LA9661-5 | Presumed responsive | |||
Concept | LA6682-4 | Unknown Significance | |||
Concept | LA6675-8 | Benign | |||
Concept | LA6674-1 | Presumed Benign | |||
Concept | LA9662-3 | Presumed non-responsive | |||
Concept | LA25392-4 | Increased function | |||
Concept | LA25393-2 | Normal function | |||
Concept | LA25395-7 | Decreased function | |||
Concept | LA25394-0 | Poor function | |||
include | http://snomed.info/sct | ||||
Concept | 444734003 | Does not meet eligibility criteria for clinical trial (finding) | |||
Concept | 399223003 | Patient eligible for clinical trial (finding) |
Unable to generate expansion - see errors